Compass Therapeutics, Inc.

NASDAQ:CMPX

Biotechnology

Healthcare
$0.61 -1.46%

-$0.03 today

Market cap
$109.26M
Beta
0.74
P/E (TTM)
-5.5
EPS (TTM)
-$0.37
52W Low $1.61High $6.88

Volume 2.90M

Average 7.64M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$72.84M

FY 2025 · Annual

Net Income

-$66.49M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue000850K0
Cost of Revenue00001.47M
Gross Profit000850K(1.47M)
Gross Margin———100.0%—
Research & Development20.34M30M38.12M42.34M55.97M
Selling, General & Admin10.93M11.66M12.24M15.13M16.87M
Operating Expenses81.88M41.66M50.36M57.48M71.37M
Depreciation & Amortization1.62M1.9M1.89M1.75M1.47M
EBITDA(80.19M)(34.96M)(40.6M)(47.62M)(65.02M)
EBITDA Margin———-5602.6%—
Operating Income(81.88M)(41.66M)(50.36M)(56.63M)(72.84M)
Operating Margin———-6661.8%—
Interest Income29K2.36M7.9M7.3M6.35M
Interest Expense370K2.36M000
Other Income / Expenses(299K)2.43M7.87M7.25M6.35M
Income Before Tax(82.18M)(39.23M)(42.49M)(49.38M)(66.49M)
Pre-Tax Margin———-5808.8%—
Income Tax Expense00000
Net Income(82.18M)(39.23M)(42.49M)(49.38M)(66.49M)
Net Margin———-5808.8%—
EPS (Basic)(1.31)(0.35)(0.33)(0.36)(0.42)
EPS (Diluted)(1.31)(0.35)(0.33)(0.36)(0.42)
Weighted Avg Shares62.87M105.19M127.03M137.11M157.7M
Weighted Avg Shares (Diluted)62.87M105.19M127.03M137.11M157.7M

CMPX Earnings Waterfall · TTM

NASDAQ:CMPX · Revenue to Net Income

Key Ratios

EPS$-0.43
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-10.6
P/S Ratio0.0

Analysis

$0 of revenue converted into -$68.2M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-0.43, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 10, 2026
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 9, 2026
4Statement of changes in beneficial ownershipOct 2, 2026
4Statement of changes in beneficial ownershipSep 25, 2026

How much revenue does CMPX generate?

Compass Therapeutics, Inc. (CMPX) reported $0.00 of revenue in fiscal 2025.

Is CMPX profitable?

Compass Therapeutics, Inc. (CMPX) reported -$66.49M of net income.